The life sciences industry in Turkey has been experiencing significant growth and development in recent years, and this trend is expected to continue into 2024. The sector covers pharmaceuticals, biotechnology, medical devices, and healthcare services, and plays a crucial role in the country's economy and public health system. 

According to the latest statistics, the Turkish life sciences industry is projected to grow at a compound annual growth rate (CAGR) of around 6% from 2021 to 2024. This growth is driven by various factors, including the increasing demand for healthcare services due to the country's growing and aging population, as well as the government's continued investment in the healthcare sector. 

One of the key drivers of growth in the Turkish life sciences industry is the pharmaceutical sector. Turkey has a large and dynamic pharmaceutical market, with a strong domestic manufacturing base and a growing number of domestic and international pharmaceutical companies operating in the country. In 2020, the Turkish pharmaceutical market was valued at around $16 billion, making it one of the largest in the region.

Read full article at Lexolology